Avicanna Q2 FY26 adjusted EBITDA loss widens to $0.36 million; revenue falls 8% to $5.64 million
Reuters2026/08/14 22:30- Avicanna posted Q2 revenue of $5.64 million, down 8% year over year on Veterans Affairs Canada reimbursement cuts.
- Gross margin climbed 6 percentage points to 57%, supported by a higher mix of proprietary products.
- Adjusted EBITDA loss widened to $0.36 million from $0.25 million a year earlier as the revenue drop outweighed cost efficiencies.
- Proprietary product units rose 33% year over year to 67,174, including 48% quarter-over-quarter growth.
- QUIX rapid-onset portfolio set for a Q3 launch with more than 35 commercial listings secured; management expects positive adjusted EBITDA in H2 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
OPEC+ agrees to keep oil output policy unchanged for October
US military strikes Iranian oil tanker, triggering geopolitical risks as Brent crude nears $97 mark
Following the US military's attack on Iranian oil tankers and Iran's announcement of new restricted navigation zones outside the Strait of Hormuz, market concerns over prolonged disruptions in key energy transport routes have intensified, leading to a sharp rise in international oil prices.
Geopolitical tensions overshadowing production cuts: OPEC+ maintains quotas unchanged, paper adjustments fail to resolve physical supply dilemmas
OPEC+ major oil producers, led by Saudi Arabia and Russia, held a monthly video conference last Sunday and decided to keep the crude oil production quota for October unchanged, continuing the previous tone of stable production following a series of symbolic production increases.
IX Biopharma seeks SGX-ST trading halt lift for shares in Singapore
Crypto prices
More
